A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a ...

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according ...

“This is the first step,” said Dr. Robert Vonderheide, president-elect of the American Association for Cancer Research and ...

Biotech company Moderna ($MRNA) saw its shares fall by as much as 25% on Thursday, October 22, despite positive results from ...

The vaccine was custom-brewed for each patient to match their tumor. It teaches the patient’s immune system to watch out for ...